Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJan 13, 2026
DataAggregated Company Financials
Companies14
  • 7D4.1%
  • 3M10.7%
  • 1Y27.3%
  • YTD3.0%

Over the last 7 days, the Pharma industry has risen 4.8%, driven by gains from AstraZeneca of 5.5%. In the last 12 months, the industry was up 28%. Earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 13 Jan 2026UK£332.3bUK£89.4bUK£14.6b21.2x22.8x3.7x
Thu, 11 Dec 2025UK£319.1bUK£89.8bUK£14.7b20.8x21.8x3.6x
Sat, 08 Nov 2025UK£309.0bUK£90.4bUK£14.8b21.1x20.9x3.4x
Mon, 06 Oct 2025UK£297.8bUK£87.6bUK£11.7b19.4x25.5x3.4x
Wed, 03 Sep 2025UK£281.4bUK£87.9bUK£11.8b21.6x23.9x3.2x
Fri, 01 Aug 2025UK£272.2bUK£88.7bUK£11.4b28.4x23.8x3.1x
Sun, 29 Jun 2025UK£256.1bUK£85.8bUK£10.5b25.8x24.3x3x
Tue, 27 May 2025UK£263.4bUK£86.2bUK£10.6b27x24.9x3.1x
Thu, 24 Apr 2025UK£257.7bUK£86.6bUK£9.6b27.1x26.9x3x
Sat, 22 Mar 2025UK£284.4bUK£87.8bUK£9.7b32.7x29.4x3.2x
Mon, 17 Feb 2025UK£282.8bUK£88.9bUK£9.5b30.6x29.9x3.2x
Wed, 15 Jan 2025UK£225.2bUK£76.7bUK£7.9b30.9x28.4x2.9x
Fri, 13 Dec 2024UK£225.7bUK£74.9bUK£7.7b32.1x29.3x3x
Sun, 10 Nov 2024UK£217.2bUK£72.6bUK£7.6b30.7x28.6x3x
Tue, 08 Oct 2024UK£251.2bUK£72.2bUK£9.0b31.1x27.8x3.5x
Thu, 05 Sep 2024UK£277.7bUK£72.0bUK£9.0b41.3x31x3.9x
Sat, 03 Aug 2024UK£266.8bUK£72.9bUK£9.0b38.9x29.6x3.7x
Mon, 01 Jul 2024UK£261.5bUK£71.8bUK£9.6b29.6x27.3x3.6x
Wed, 29 May 2024UK£265.2bUK£71.4bUK£9.5b32.4x27.8x3.7x
Fri, 26 Apr 2024UK£261.0bUK£71.7bUK£10.1b32.2x26x3.6x
Sun, 24 Mar 2024UK£240.9bUK£70.9bUK£9.8b31.3x24.7x3.4x
Tue, 20 Feb 2024UK£236.5bUK£69.8bUK£9.6b36x24.6x3.4x
Thu, 18 Jan 2024UK£237.7bUK£69.0bUK£10.7b36.3x22.3x3.4x
Sat, 16 Dec 2023UK£227.4bUK£69.0bUK£10.7b33.9x21.3x3.3x
Mon, 13 Nov 2023UK£224.7bUK£70.4bUK£10.9b53x20.7x3.2x
Wed, 11 Oct 2023UK£246.2bUK£70.3bUK£10.4b74.9x23.7x3.5x
Fri, 08 Sep 2023UK£238.4bUK£69.7bUK£10.3b53.5x23.3x3.4x
Sun, 06 Aug 2023UK£238.4bUK£68.9bUK£10.2b52.8x23.5x3.5x
Tue, 04 Jul 2023UK£230.5bUK£67.8bUK£7.9b55.1x29.2x3.4x
Thu, 01 Jun 2023UK£247.8bUK£68.7bUK£8.0b55.5x31x3.6x
Sat, 29 Apr 2023UK£254.1bUK£68.2bUK£7.9b55.7x32x3.7x
Mon, 27 Mar 2023UK£239.8bUK£69.9bUK£6.9b57.2x34.7x3.4x
Wed, 22 Feb 2023UK£252.1bUK£70.2bUK£7.2b58.5x35.1x3.6x
Fri, 20 Jan 2023UK£247.7bUK£79.2bUK£6.3b38.5x39.4x3.1x
Price to Earnings Ratio

39.4x


Total Market Cap: UK£247.7bTotal Earnings: UK£6.3bTotal Revenue: UK£79.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 27.1x202420252026
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.9x which is lower than its 3-year average PE of 27.1x.
  • The 3-year average PS ratio of 3.4x is lower than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 32% per year over the last three years.
  • Revenues for these companies have grown 4.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.48%
Healthcare4.05%
Pharma4.10%
Pharma4.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£141.205.5%
+UK£11.4b		30.5%PE31.4x
GSK GSKUK£18.773.1%
+UK£2.3b		41.0%PE13.7x
HCM HUTCHMED (China)UK£2.2511.4%
+UK£197.7m		-7.0%PE5.6x
HIK Hikma PharmaceuticalsUK£15.652.5%
+UK£84.2m		-22.1%PE12.6x
AGY Allergy TherapeuticsUK£0.124.4%
+UK£30.7m		60.3%PS13.2x

Latest News

HLN
UK£3.62
Haleon
7D
-2.7%
1Y
-1.6%

HLN: Modest Uplift In Outlook Will Balance Execution And Valuation Risks

Analysts have raised their Haleon price target by £0.10, from 507 GBp to 517 GBp. This change reflects updated assumptions for slightly higher revenue growth, a small adjustment to profit margins, and a modestly lower future P/E. Analyst Commentary The latest price target move to 517 GBp signals that at least one research house still sees room for upside in Haleon, but the change is relatively modest.
GSK
UK£18.77
GSK
7D
3.1%
1Y
41.0%
AZN
UK£141.20
AstraZeneca
7D
5.5%
1Y
30.5%
HCM
UK£2.25
HUTCHMED (China)
7D
11.4%
1Y
-7.0%
HIK
UK£15.65
Hikma Pharmaceuticals
7D
2.5%
1Y
-22.1%

HIK: Leadership Reset And 2030 Revenue Ambition Will Support Earnings Outlook

Analysts have reduced their fair value estimate for Hikma Pharmaceuticals from £22.66 to £22.00 per share, reflecting a combination of more cautious views on management, strategy and catalysts, together with recent recalibrations of price targets across covering banks. Analyst Commentary Recent Street research on Hikma Pharmaceuticals shows a split between more cautious and more optimistic voices, with differing price targets and ratings feeding into the reduced fair value estimate.
AGY
UK£0.12
Allergy Therapeutics
7D
4.4%
1Y
60.3%
ANCR
UK£2.50
Animalcare Group
7D
5.0%
1Y
4.2%
EAH
UK£1.14
ECO Animal Health Group
7D
7.5%
1Y
78.1%

Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%

Dec 04
Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%
POLB
UK£0.048
Poolbeg Pharma
7D
11.6%
1Y
-2.2%
NFX
UK£0.0028
Nuformix
7D
-17.6%
1Y
489.5%
IMM
UK£0.069
ImmuPharma
7D
-4.7%
1Y
83.2%
N4P
UK£0.005
N4 Pharma
7D
-4.8%
1Y
-23.1%